The pitch sounds irresistible: feed your claims data into a machine learning model and watch it surface denial patterns you never knew existed. In many ways, that pitch is true. But the gap between pattern recognition and actionable revenue recovery is exactly where most AI-only approaches break down.
Across the healthcare revenue cycle, denials have grown more complex, more voluminous, and more costly to resolve. Payers continue to tighten authorization requirements, apply new clinical criteria mid-contract, and leverage their own algorithms to identify claims worth scrutinizing. The pressure on provider-side RCM teams has never been higher—and it’s no surprise that machine learning has entered the conversation as a potential equalizer.
What follows is an honest look at where machine learning genuinely helps, where it falls short, and why the most effective denials programs today combine intelligent tooling with experienced human judgment.
What Machine Learning Actually Does Well
Let’s start with credit where it’s due. Machine learning-based denial analytics have made measurable inroads in three specific areas: pattern detection at scale, predictive flagging before submission, and root cause categorization.
The Scale Problem It Solves
$262B – Estimated annual waste from denied & rejected claims (AHA)
15-20% – Average initial denial rate across U.S. health systems
65% – Of denials can be overturned, yet many still go unaddressed.
At this volume, no team of billing specialists can manually review every denial pattern across payers, procedure codes, facilities, and time periods. Machine learning changes that calculus. A well-trained model can ingest millions of historical claims, map denial outcomes to upstream variables, and surface correlations that would take a human analyst weeks to find, if they found them at all.
Predictive denial prevention is another genuine win. By scoring claims before submission based on historical denial likelihood, machine learning tools give billing teams a prioritized worklist. A claim with a 70% predicted denial probability for a given payer gets reviewed before it goes out. That’s not magic, it’s applied probability. But it works, and when paired with clean documentation workflows, it moves the needle on first-pass acceptance rates.
Pattern recognition at scale is a legitimate capability. The mistake is assuming that identifying a pattern is the same as knowing what to do about or why it exists in the first place.
Where the Model Ends and the Work Begins
Here’s the honest part. Machine learning models are trained in historical data and payer behavior is not static. CMS coverage determinations shift. Commercial payers revise clinical criteria. Local coverage decisions get updated mid-year. A model trained on last year’s adjudication patterns may confidently score a claim as low risk for a denial category that a payer quietly changed three months ago.
This is not a solvable problem by adding more data. It’s a structural limitation of any system that learns from the past to predict the future in an environment where the rules keep changing.
What Machine Learning Still Cannot Do
Interpret payer intent – When a denial comes back as “not medically necessary,” the model sees a denial code. An experienced specialist knows whether this payer uses that code as a default stall tactic or as a genuine clinical objection—and responds accordingly.
Navigate payer relationships – Escalation paths, peer-to-peer review timing, and the nuance of when to appeal versus accept a write-off are relationship-dependent. No algorithm carries institutional memory of how a specific payer handles disputes.
Adapt to policy shifts in real time – Model retraining cycles lag behind payer policy updates by weeks or months. A human reviewer who monitors payer bulletins and LCD updates catches changes that a static model misses entirely.
Write the appeal that wins – Machine-generated appeal letters are easy to spot, and payer reviewers recognize templated language immediately. To be effective, appeals must be tailored to the specific payer, grounded in clinical expertise, and built around a clear, well-structured narrative that demonstrates the clinical evidence supporting the plan of care.
“The algorithm tells you what’s happening. It takes a person to understand why—and what to do next.”
The Strategic Case for Human-Led RCM
The practices seeing the best denial outcomes right now are not the ones with the most sophisticated AI stack. They’re the ones that have built workflows where machine intelligence and human expertise operate in sequence—not in competition.
In this model, machine learning handles the triage. It scores, flags, categorizes, and prioritizes. It frees specialists from spending their first hour of every morning sorting through claim queues to figure out what needs attention. That’s real time savings, and it’s not trivial.
But the specialist still makes the call. They review the flagged denial with full context, the patient’s history, the payer’s track record on similar claims, the clinical documentation available, and the strategic cost-benefit of appeal versus write-off. They write the appeal with specificity. They know when to request a peer-to-peer and how to frame the conversation. They track whether the payer’s behavior on a specific denial category has shifted and escalate that intelligence upstream so the team can respond before it becomes a systemic revenue leak.
That is not a workflow that AI replaces. It’s a workflow that AI makes possible at a higher volume and with better information.
What This Means for How You Evaluate RCM Partners
If you’re assessing RCM partners or building an internal denials management function, the question to ask is not “do you use AI?” Every serious vendor does or will. The question is: what does the human layer look like, and how does it interact with technology?
A vendor who leads with their platform and describes their team as “oversight” has the relationship backwards. The team should be the strategy; the platform should be the infrastructure that supports it. When a payer introduces a new prior authorization policy that creates a wave of unexpected denials, you want a team that catches it on day three, not a model that flags it six weeks later when the pattern is statistically significant.
You also want accountability. Algorithms don’t attend your monthly revenue reconciliation meetings. They don’t explain why write-offs spiked in a particular payer category or what’s being done about it. That accountability lives with people—which is exactly why people need to remain at the center of denials strategy, regardless of how good the tooling gets.
The Action RCM Perspective
We use machine learning where it delivers value: identifying patterns, prioritizing worklists, and uncovering trends that can be fed back to hospitals to drive improvement. But we’ve built our practice on the conviction that revenue cycle outcomes are ultimately determined by the quality of human judgment applied at critical decision points.
AI doesn’t win appeals. It doesn’t build payer relationships. It doesn’t read between the lines of a denial code and recognize a payer trend before it becomes a revenue problem. Our specialists do. The technology makes them faster and more informed—and that’s exactly how it should work.
If you’re evaluating your current denials program and want to understand where human expertise is being under-leveraged, we’re glad to take a look. The opportunity is almost always there.
